obesity
PreventionGenetics Nabs FDA Approval for Obesity Drug Companion Diagnostic
The test detects variants in the POMC, PCSK1, and LEPR genes to identify individuals eligible for treatment with Rhythm Pharmaceuticals' recently approved Imcivree.
Phenomix, Mayo Clinic Ink Licensing Deal for Obesity Phenotype Blood Test
Phenomix said its MyPhenome test uses a multiomics and artificial intelligence platform to predict patients' obesity phenotypes.
The firm, Phenomix Sciences, anticipates that its test will help drive adoption of medications for obesity at a time when patients are reluctant to take them.
Bio-Rad, Bioaster, Genetic Analysis Team Up on Microbiome Diagnostics for Metabolic Disorders
The project builds on a collaboration between Bio-Rad and Genetic Analysis using the GA-map clinical test for gut dysbiosis.
Mayo Clinic Spinout Phenomix Sciences Launches $1M Seed Funding Round
The firm will use the financing to commercialize a test that utilizes metabolomic and DNA biomarkers to characterize obesity and guide weight loss.